An immunoaffinity method purified CJC‑1295 together with other peptides from plasma, serum or urine before mass spectrometry.
In plain wordsIn lab tests, a purification method extracted CJC‑1295 and other peptides from blood or urine samples before detection.
- Peptide
- CJC-1295 (with DAC)
- Outcome
- Not applicableImmunoaffinity purification of CJC-1295 from plasma, serum or urine
- Study
humann: not reported in source
plasma, serum or urine- Outcome group
- Pharmacokinetics · Pharmacology
Source sentences
growth hormone releasing hormone (GH-RH(1-29)) and CJC-1295 (GH-RH analogue), LongR(3)-IGF-1 and IFG-1) were simultaneously purified from plasma/serum or urine
1 context sentence(design, population, supporting numbers)
With limits of detection for each target compound ranging in the low pg/mL level (urine), the method enables the determination of urinary peptides at physiologically relevant concentrations.
In this study, CJC-1295 (with DAC) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking CJC-1295 (with DAC).